| 영문 | conception | 한글 | 수태, 임신 |
|---|---|---|---|
| 설명 | 난자가 착상되어 임신이 시작된 것. 임신은 수정으로 시작하여 출산으로 끝난다. 수정은 정자와 난자가 자궁관 내에서 결합하는 것을 이르는 말이며, 임신-성립의 시작이다. 난자는 수정하여 발육을 개시하는 능력이 배란 후 몇 시간 이내이고, 정자는 약 48시간인데, 드물게는 약 1주간이나 유효한 경우도 있으며, 사정 후 2~3시간만에 자궁관의 난소 가까이까지 이른다. 따라서 대개는 정자가 먼저 수정장소(대체로 자궁관의 팽대부)에 가서 대기하다가 난자가 도달하면 정자 중 하나만이 난자와 결합하는 것으로 보고 있다. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| ERPC | evacuation of retained products of conception |
| FDP(s) | 1) Fibrinolytic split Products(= FSP) 2) Fibrinogen Degradation Products |
| FSP | familial spastic paraplegia; fibrin split products; fibrinogen split products; fine suspended partic... |
| dpc | days post conception |
|---|---|
| AIMS | Abnormal Involuntary Movement Scale |
| AIM | abnormal involuntary movement |
| AUB | Abnormal Uterine Bleeding |
| Awd | Abnormal wing disc |
| conception | <biology, gynaecology> The onset of pregnancy, marked by implantation of the blastocyst, the formation of a viable zygote. Origin: L. Conceptio (18 Nov 1997) |
|---|---|
| imperative conception | A concept that does not arise from association but appears spontaneously and refuses to be banished. (05 Mar 2000) |
| abnormal | Not normal, contrary to the usual structure, position, behaviour or rule. (06 Oct 1997) |
| abnormal cleavage of cardiac valve | Congenital malformation of a valve leaflet with a defect extending from the free margin. (05 Mar 2000) |
| abnormal correspondence | Abnormal correspondence, a condition, frequent in strabismus, in which corresponding retinal points do not have the same visual direction; the fovea of one eye corresponds to an extrafoveal area of the fellow eye. Synonym: abnormal correspondence. (05 Mar 2000) |
| abnormal heart chamber dimensions | <radiology> Left ventricular volume overload, left ventricular hypertrophy, right ventricular volume overload, right ventricular hypertrophy, fixed subvalvular aortic stenosis, hypoplastic left/right ventricle; common ventricle, congestive cardiomyopathy (12 Dec 1998) |
| abnormal occlusion | An arrangement of the teeth which is not considered to be within the normal range of variation. (05 Mar 2000) |
| abnormal placental size | <radiology> TOO BIG (greater than5cm in sections obtained at right angles to the long axis), maternal disease, diabetic mothers (= villous oedema), intrauterine infections, anaemic mothers (= normal histology), foetal disease, erythroblatosis foetalis (= villous oedema and hyperplasia), umbilical vein obstruction, foetal high output failure, large chorioangioma, sacrococcygeal teratoma, arteriovenous fistula too small, preeclampsia (associated with placental infarcts in 33-60%) (12 Dec 1998) |
| reflex, abnormal | Abnormal, involuntary response to a stimulus which includes hyperreflexia, hyporeflexia, and areflexia. (12 Dec 1998) |
| cellular immunodeficiency with abnormal immunoglobulin synthesis | An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal. Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia. (05 Mar 2000) |
| haemoglobins, abnormal | Haemoglobins altered in their genetically determined molecular structure, resulting in a characteristic complex of vlinival and laboratory abnormalities. The specific features of the abnormal haemoglobins are related to variation of the composite globin polypeptide chains. (12 Dec 1998) |
| pupillary functions, abnormal | Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation. (12 Dec 1998) |
| fibrinogens, abnormal | Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. (12 Dec 1998) |
| biological products | Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from biological factors in that the latter are compounds with biological or physiological activity made by living organisms. (12 Dec 1998) |
| blood products | Biopharmaceutical products purified from human blood, such as the blood clotting factor VIII used to treat haemophiliacs. (Recombinant factor VIII is also on the market.) The term also refers to biopharmaceuticals that act on blood or the cells that make blood. These products are often produced by the cells themselves, but in such tiny amounts that extracting them from blood is impractical, and so they are genetically engineered. (14 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|